BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7728163)

  • 21. Aspects of member satisfaction under two types of health delivery systems: a comparison of prepaid group practice HMO members and a Blue Cross/Blue Shield matched control group.
    Sorensen AA; Wersinger RP
    Group Health J; 1980; 1(2):33-41. PubMed ID: 10247921
    [No Abstract]   [Full Text] [Related]  

  • 22. 'Model' rural IDS suffers $49M legal hit in battle with Blues.
    Greene JL; Rudd T
    Healthc Syst Strategy Rep; 1995 Jan; 12(2):1-2, 5. PubMed ID: 10152386
    [No Abstract]   [Full Text] [Related]  

  • 23. Judge in Marshfield appeals case, clarifies views on MFNs, markets.
    Healthc Syst Strategy Rep; 1995 Nov; 12(24):5-7. PubMed ID: 10154257
    [No Abstract]   [Full Text] [Related]  

  • 24. Marshfield verdict partly overturned; panel orders retrial.
    Jaklevic MC
    Mod Healthc; 1995 Sep; 25(39):4-5. PubMed ID: 10151421
    [No Abstract]   [Full Text] [Related]  

  • 25. Blues' discount policy seen as antitrust issue.
    Burda D
    Hospitals; 1986 Nov; 60(21):36. PubMed ID: 3770662
    [No Abstract]   [Full Text] [Related]  

  • 26. Policy makers set sights on regulating risk-bearing groups.
    Capitation Manag Rep; 2001 Mar; 8(3):44-7, 33. PubMed ID: 11299644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health maintenance organizations and the role of antitrust law.
    Kissam PC
    Duke Law J; 1978 May; (2):487-541. PubMed ID: 10239065
    [No Abstract]   [Full Text] [Related]  

  • 28. Wis. insurer suing physicians in reversal of typical roles.
    Burda D
    Mod Healthc; 1994 Mar; 24(13):33. PubMed ID: 10132355
    [No Abstract]   [Full Text] [Related]  

  • 29. Court overturns jury's verdict on Blue Cross antitrust violation claim.
    Kazon PM
    Bus Health; 1988 Nov; 6(1):44-5. PubMed ID: 10290529
    [No Abstract]   [Full Text] [Related]  

  • 30. In nearly complete legal 180, federal appeals court spares rural Wisc. IDS.
    Steele CJ
    Healthc Syst Strategy Rep; 1995 Sep; 12(20):8-10. PubMed ID: 10184451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall of a Kaiser Permanente expansion region.
    Gitterman DP; Weiner BJ; Domino ME; McKethan AN; Enthoven AC
    Milbank Q; 2003; 81(4):567-601. PubMed ID: 14678480
    [No Abstract]   [Full Text] [Related]  

  • 32. 26 states seek antitrust ruling.
    Jaklevic MC
    Mod Healthc; 1996 Feb; 26(8):4. PubMed ID: 10154762
    [No Abstract]   [Full Text] [Related]  

  • 33. Capitated physicians score victory as two plans settle antitrust suit.
    Capitation Manag Rep; 2004 Jan; 11(1):6-8, 1. PubMed ID: 15002203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Legal. Experts debate the impact of antitrust suit against Michigan Blues.
    Taylor M
    Hosp Health Netw; 2010 Dec; 84(12):12, 14. PubMed ID: 21268792
    [No Abstract]   [Full Text] [Related]  

  • 35. Nine New Jersey hospitals charge Blue Cross with antitrust. Beth Israel Hospital et al. v. Blue Cross and Blue Shield of New Jersey, Inc.
    Hudson T
    Hosp Health Netw; 1993 Sep; 67(18):62. PubMed ID: 8369840
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitrust antagonists. West Penn claims UPMC, Highmark conspired.
    Blesch G
    Mod Healthc; 2009 Apr; 39(17):10. PubMed ID: 19422119
    [No Abstract]   [Full Text] [Related]  

  • 37. Feds challenge Marshfield ruling.
    Jaklevic MC
    Mod Healthc; 1995 Oct; 25(41):33. PubMed ID: 10152052
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical participation in control of open-panel medical prepayment plans.
    Bryan JE
    Am Fam Physician; 1979 Dec; 20(6):159-60, 164-5. PubMed ID: 517380
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitrust action averted. Agreement with Pa. attorney general allows UPMC merger to proceed.
    Becker C
    Mod Healthc; 2001 Oct; 31(44):14-5. PubMed ID: 11715731
    [No Abstract]   [Full Text] [Related]  

  • 40. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.